Global Gene Amplification Technologies Market Size study, By Technology (PCR-based Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence Based Amplification, Strand Displacement Amplification, Multiple Displacement Amplification, Ro

Global Gene Amplification Technologies Market Size study, By Technology (PCR-based Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence Based Amplification, Strand Displacement Amplification, Multiple Displacement Amplification, Rolling Circle Amplification, Ramification Amplification, Others) By Downstream (Whole Genome Amplification, Exome Sequencing, SNP Genotyping Arrays, Array CGH, Hybridization, Others) By Sample Type (Single Cell, FFPE, Others) By Product (Instruments, Kits & Reagents, Services) By End Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others) and Regional Forecasts 2021-2027

Global Gene Amplification Technologies Market is valued at approximately USD 26.28 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 2.0 % over the forecast period 2021-2027. Gene Amplification is a technology used by scientists for the amplification of gene sequence in a test tube. It is basically a laboratory technique based on a polymerase chain reaction. In gene amplification technology number of copies of a gene are increased without affecting proportional increase in other genes The increasing incidence of chronic diseases has led to the adoption of Gene Amplification Technologies across the forecast period. For Instance:
According to World Health Organization, the cases of diabetes are increasing rapidly. In 2019, number of deaths caused by diabetes was 1.5 million. According to Food and Agriculture Organization (FAO), the incidences of chronic diseases is increasing rapidly. It is estimated that by 2020 chronic diseases will cause the highest percentage of deaths globally. 75 % of deaths due to stroke and 71 % of death caused due to heart disease. Rising R&D in molecular diagnostics arena and genomics pushes the market growth of gene amplification technologies market However, the increasing cost of PCR instruments impedes the growth of the market over the forecast period of 2021-2027. Also, with expanding applications in cell & gene therapies the adoption & demand for gene Amplification Technologies is likely to increase the market growth during the forecast period.

The regional analysis of the global Gene Amplification Technologies market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the significant region across the world in terms of market share owing to increasing genetic research programs. Whereas Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as rising government initiatives for the advancement of health care infrastructure, rising activities in molecular diagnostics space and genomics would create lucrative growth prospects for the Gene Amplification Technologies market across Asia-Pacific region.

Major market player included in this report are:
Con QIAGEN
New England Biolabs
Illumina Inc.
Yikang Gene
Bio-Rad Laboratories
Silicon Biosystems
Merck KGaA
Promega Corporation
Takara Bio Inc.
Danaher Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
PCR-based Amplification
Loop-mediated Isothermal Amplification
Nucleic Acid Sequence Based Amplification
Strand Displacement Amplification
Multiple Displacement Amplification
Rolling Circle Amplification
Ramification Amplification
Others

By Downstream Application:
Whole Genome Amplification
Exome Sequencing
SNP Genotyping Arrays
Array CGH
Hybridization
Others
By Sample:
Single Cell
FFPE
Others
By Product:
Instruments
Kits & Reagents
Services
By End-use:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Gene Amplification Technologies Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Con QIAGEN
New England Biolabs
Illumina Inc.
Yikang Gene
Bio-Rad Laboratories
Silicon Biosystems
Merck KGaA
Promega Corporation
Takara Bio Inc.
Danaher Corporation